Japanese health spending hits record high
This article was originally published in Scrip
Japan's total medical expenditure under health insurance schemes rose by 3% to a record ¥33,400 billion ($321 billion) in the fiscal year to March 31st, driven in large part by an expanding aged population, new official data show. The increase came despite cost cutting measures over the last few years which have included increases in patient co-payments. Average per capita costs were up by 3% to ¥262,000 while costs for patients aged over 70 rose by 2% to ¥757,000, the central social insurance medical council (Chuikyo) reported.
You may also be interested in...
Positive clinical results pave path forward for Japanese firm’s potential istradefylline successor.
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.